2007). In Alzheimer's dementia (AD), which is frequently accompanied by cholinergic deficiency, attention and executive ability decline during early disease stages (White et al. 1977; Haxby et al. 1990). Acetylcholine‐esterase (AChE) inhibitors are thought to delay cognitive decline, but also to improve attentional deficits in individuals at high risk of developing dementia (Winblad et al. 2001; Salloway et al. 2004). Here, ACHE is linked to Alzheimer disease.